Kuehn Law, PLLC is investigating whether certain officers and directors of Kymera Therapeutics, Inc. breached their fiduciary duties through potential self-dealing. This legal probe could lead to damages for shareholders and reforms in corporate governance. Long-term shareholders of Kymera Therapeutics are encouraged to contact the law firm for a free consultation to protect their rights. The investigation highlights concerns about management integrity and shareholder protections at the company.
Kymera Therapeutics, Inc. is the subject of a legal investigation, while Pluang's health sector market data shows 45 of 100 priced US health stocks rose and 50 fell today. Notable movers include RXRX at USD 3.98 with a 1-day change of -1.24% and 100% buy order activity, BDX at USD 184.18 with a 1.21% gain and 100% sell order activity, and FLNA at USD 0.92 with a -1.05% change and 73% buy order activity. These figures are as of Sep 30, 2026 19:11 WIB.
Conagra Brands reported a 1.4% decline in first-quarter revenue to $2.6 billion, with organic net sales down 1.1%, causing shares to fall 4.6%. Despite the sales drop, adjusted earnings per share rose 5.1% to $0.41, beating analyst estimates of $0.28...
Deutsche Bank has increased its target price for Vodafone Group PLC to 160p from 150p and maintained a 'buy' rating, citing fewer risks and a stronger earnings and cash flow outlook. The bank noted improved investor sentiment following Xavier Niel’s ...
Cisco's stock recently pulled back, presenting a buying opportunity before the October 2 record date for its next 42-cent quarterly dividend. The company benefits from accelerating growth driven by AI data center demand, with fiscal 2026 revenue up n...
Meta's stock has surged 25% in the past month as the company invests heavily—over $130 billion—in AI technology, aiming to transform its advertising business. Despite strong revenue growth and increased AI-driven ad engagement, Meta faces margin pres...
Cinemark and CJ 4DPLEX announced a deal to add 20 new SCREENX auditoriums—17 in the U.S. and 3 in Latin America—by 2026. This expansion increases Cinemark's U.S. SCREENX locations to 30, enhancing premium immersive movie experiences ahead of major re...
